Tags: biotechnologydrug developmentDrug pricesresearchpharma
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | 1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | Seagen and Astellas announce results from EV-302 study - over 1 year ago | |
2 | Hrag Vartanian Hyperallergic Art Critic Futurist. In Diaspora | We Are Also the Darkness After the Big Explosion - 16 days ago | |
3 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: Galapagos to split itself into two companies as part of turnaround plan - about 2 months ago | |
4 | Nick Gibbs Autocar Car stuff. London | Inside Stellantis’s peace mission to defuse wrath at Tavares - about 2 months ago | |
5 | Lakshmi Rivera Amin Hyperallergic Artist. New York City | A View From the Easel - about 2 months ago A View From the Easel - 3 months ago A View From the Easel - 5 months ago A View From the Easel - 6 months ago A View From the Easel - 6 months ago A View From the Easel - about 1 year ago A View From the Easel - about 1 year ago A View From the Easel - about 1 year ago A View From the Easel - about 1 year ago | |
6 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Testing Elacestrant With Other Targeted Drugs for Metastatic Breast Cancer - about 2 months ago | |
7 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
8 | Tara Haelle MedPage Today Sci/health journalist.
Feminist.
Educator.
Photographer.
Author. DFW | ||
9 | Stewart Burnett Automotive World Voice of the remarketing & used car sectors. | Streetscooter owner e.Volution files for insolvency - 3 months ago | |
10 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | A win for Apellis, a setback for Astellas - 3 months ago Lilly has more positive data on its weekly insulin - 6 months ago |